Articles tagged with Gastrointestinal Disorders
The Experimental Drug Development Centre's EBC-129, an antibody-drug conjugate targeting pancreatic cancer, has received FDA fast track designation. The treatment is undergoing Phase 1 clinical trials and aims to provide new treatment options for patients with solid tumours.
Researchers discovered biomarkers in gut bacteria and metabolites that can help diagnose and treat gastrointestinal diseases. The study found that certain biomarkers could predict multiple diseases, including gastric cancer and inflammatory bowel disease.
Researchers analyzed over 1,000 stool samples to develop a new diagnostic method for intestinal diseases. The study successfully identified hidden infections, including elusive parasites and RNA viruses, providing valuable insights into the infection process.
A new study published in Nature reveals that maintaining a healthy diet is the most effective way to rebuild a depleted gut microbiome, outperforming fecal transplants. The research shows that a Western-style diet can severely impact the microbiome's ability to defend against pathogens.
This study found that intestinal depletion of TM6SF2 exacerbates high-fat diet-induced MASLD by altering the gut microbiota and liver lipid content. The absence of TM6SF2 also led to increased serum biomarkers associated with MASLD progression.
A new study reveals that protein sources in an animal's diet significantly alter the gut microbiome, with some having extreme effects. The researchers found that diets high in brown rice, yeast, or egg whites led to changes in amino acid metabolism and complex sugar degradation.
Researchers from UCalgary and Chinese University of Hong Kong found that IBD progresses through four predictable epidemiological stages as it spreads globally. The study forecasts a major rise in IBD prevalence in Canada by 2045, with countries in North America, Europe, and Oceania reaching Stage 3 (compounding prevalence). Developing ...
Researchers identified five blood proteins that can predict liver disease up to 16 years before symptoms. The combined levels of these proteins achieved high accuracy in predicting disease onset and progression, suggesting potential for early diagnosis and treatment.
Bonn researchers found higher numbers of type 3 innate lymphoid cells in duodenum tissue of FAP patients, producing interleukin-17A which stimulates ROS production and DNA damage. This suggests a local environment favoring cancer development, prompting a new approach to preventing duodenal cancer.
Researchers at Penn State have identified key immune system proteins that trigger severe inflammatory responses to parasitic eggs, which cause the disease. The study provides a better understanding of the body's response and could lead to new therapeutic approaches.
RMIT University has transferred patents and intellectual property related to the Atmo Gas Capsule, a real-time gut health monitor, to medical device company Atmo Biosciences. The capsule measures biomarkers directly at the source of production in the gut to aid diagnosis of gastrointestinal disorders.
The study directly compared Droplet-based scRNA (D-scRNA) and Picowell-based scRNA (P-scRNA) platforms for analyzing human mucosal biopsies. D-scRNA provides more detailed insights, but requires resources and may introduce contamination. P-scRNA is gentler, more resource-efficient, but less effective in capturing rare cell types.
A new review suggests a strong association between gum disease and chronic liver conditions, including cirrhosis and metabolic dysfunction. The 'oral-gut-liver axis' theory proposes that pathogenic bacteria from the mouth can exacerbate liver inflammation and fibrosis through dysbiosis and increased gut permeability.
A new study found that Clostridium difficile infection spreads more than three times more than previously thought within intensive care units, with bacteria moving between patients and hospital surfaces. The researchers tracked bacterial movement using whole genome DNA sequencing and discovered cases of potential transmission that woul...
Researchers have discovered a new probiotic bacterial strain that is 15% more effective in treating giardiasis than the existing strain. The strain, Lactobacillus johnsonii CNCM I-4884, has significant anti-Giardia activity and can transform conjugated bile salts into toxic compounds for the parasite.
Researchers at SickKids identified three new genes associated with rare childhood diarrhea, providing a diagnosis for 48% of cases. The study found that genetic testing and targeted treatments can improve the quality of life for children like Sophie, who was diagnosed with CODE at just two days old.
Researchers at Texas A&M University found age and fecal score to be important factors for screening kennel-housed dogs for subclinical Giardia infections. Kennel-housed dogs under 18 months old were more likely to test positive, while hard stool was associated with negative test status.
A recent study found that the protein tyrosine phosphatase delta (PTPRD) acts as a suppressor of the pro-inflammatory STAT3 pathway in liver cells, regulating lipid and glucose metabolism and protecting peroxisomal function. Reduced PTPRD expression was associated with signs of liver dysfunction and metabolic syndrome in humans.
Researchers have studied the mechanism of action of bioactive compounds from papaya, passion fruit, and medicinal plant extracts. Modified pectins extracted from these plants show potential as supplements or food ingredients to boost biological activity against colon cancer and gut microbiota.
A machine learning algorithm has been developed to diagnose coeliac disease with high accuracy, outperforming human pathologists in over 97 cases. The AI tool has the potential to speed up diagnosis and reduce delays in receiving an accurate diagnosis for patients suffering from this autoimmune disease.
A comprehensive study found that people with fatty liver disease have almost twice the mortality rate of the general population. The disease is caused by overweight or obesity and increases the risk of dying from various causes, including liver disease, cancer, cardiovascular disease, and infections.
This study found that aging impacts the gut microbiome composition and metabolites differently in male and female rats, influenced by biological sex and mitochondrial DNA. The researchers analyzed fecal samples from genetically diverse rats to assess bacterial changes with age, revealing more significant shifts in females.
A new study reveals that inhibiting gut cannabinoid receptor 1 (CB1R) can help protect the gut barrier and prevent alcohol-induced intestinal permeability. By targeting CB1R, researchers hope to develop a novel therapeutic approach for treating alcohol-related digestive disorders.
Recent research challenges the traditional distinction between functional dyspepsia (FD) and gastroparesis (GP), suggesting they represent a continuum of the same disease. The review highlights significant symptom overlap, shared pathophysiological mechanisms, and potential therapeutic strategies.
Patients with severe ischemic stroke show impaired gastric motility and autonomic dysfunction, with reduced normal gastric slow waves and increased sympathetic activity. These findings suggest a link between gastric myoelectrical rhythms and autonomic function in ischemic stroke.
A cross-sectional survey revealed high costs, inadequate training, and poor financing as major challenges to gastrointestinal endoscopy practice in Nigeria. Locally developed innovations have eased the practice, preventing it from collapsing.
Researchers at the Texas A&M Gastrointestinal Laboratory discovered biomarkers that can predict gastrointestinal disease risk in dogs. The study found multiple signs of high-risk disease, including inflammation and leaky guts, which can contribute to the development of GI disease if left unchecked.
A team of researchers has developed an ingestible bioimpedance sensing device that continuously monitors gastrointestinal mucosal barrier integrity wirelessly. The device can detect subtle changes in mucosal permeability, a common feature in Inflammatory Bowel Disease (IBD), enabling early detection and improved diagnosis.
This review highlights ELF4's dual role in tumor suppression and oncogenesis, modulating immune responses and tissue development. Further research is needed to decode its regulatory mechanisms and develop therapeutic interventions.
The American Society for Radiation Oncology (ASTRO) has published its first clinical guideline on radiation therapy for anal cancer, providing guidance on treatment options and techniques. The guideline recommends a combination of radiation therapy and drug therapy as the standard of care, with intensity-modulated radiation therapy (IM...
Researchers found that added sugars contribute between 7% and 21% to the risk of gastric cancer, while sodium intake is the main mediating factor. Healthy diets characterized by high vegetable and fruit consumption can reduce this risk.
A Japanese version of the Esophageal Hypervigilance and Anxiety Scale has been developed and validated for clinical use in Japan. The scale, which evaluates symptom-specific hypervigilance and anxiety for esophageal symptoms, showed validity comparable to standardized mental and physical health surveys.
ABT-263 eliminates harmful aging cells in the gut, reducing inflammation and lowering cancer risk in a mouse model of GI cancer. The study suggests that removing senescent cells could help prevent radiation-related GI cancer, highlighting the potential of senolytic drugs as a preventive treatment.
A Dartmouth-led study reveals that cystic fibrosis disrupts the maturation of the gut microbiome in infants, leading to a depletion of health-associated bacteria and potentially poor health outcomes. The study found that the microbiomes of infants with CF remained stunted or delayed in their development compared to healthy infants.
Researchers developed a 3D microscopic version of the human intestines on a chip, allowing for real-time examination of gut microbes' interactions with the human intestine. The 'Gut-Microbiome on a chip' model enables the study of complex interplay between gut microbes and health, facilitating targeted microbiome-based interventions.
Carbapenem-resistant Enterobacterales, including K. pneumoniae and E. coli, pose a significant risk to EU/EEA patients and healthcare systems. The epidemiological situation has deteriorated since 2019, with high-risk lineages spreading in hospitals.
A comprehensive study reveals that Akkermansia muciniphila breaks down sugars locked in mucus using a set of enzymes. The findings provide new insights into the molecular mechanisms behind this process and its potential applications in understanding disease and improving gut health.
Batten disease, a neurodegenerative disorder, affects the bowel wall's enteric nervous system, causing degeneration and bowel symptoms. Gene therapy has been shown to slow symptoms and extend lifespan in mice by preventing enteric neuron degeneration.
Researchers at UVA have developed computer models to target specific bacteria in specific parts of the body, reducing the chance of antibiotic resistance. This approach could lead to more effective treatments and reduce the need for broad-spectrum antibiotics.
The review summarizes findings on cellular, molecular, and systemic processes involved in ALD progression, highlighting pathways for future research. It also discusses the role of extracellular vesicles in intercellular communication and their implications for early diagnosis and therapeutic intervention.
Researchers at USF and TGH Cancer Institute found a potential link between the Western diet and chronic inflammation that drives tumor growth. Chronic inflammation fueled by poor dietary choices plays a vital role in colorectal cancer growth and progression.
A Brazilian researcher at Harvard identified serotonin as the central role in postprandial hypoglycemia, a common complication of bariatric surgery. The study found that serotonin levels increase significantly after meals in affected individuals, unlike those without symptoms.
Researchers used MRI to investigate how a gluten-free diet affects people with coeliac disease, finding improved gut symptoms but persistent issues. The study also identified changes in the gut microbiome, suggesting potential prebiotic treatments.
A new study proves a suspected link between poor sleep and MASLD, a liver disorder that affects 30% of adults. Patients with MASLD experience significant sleep fragmentation, waking up 55% more often at night.
A new prognostic model, the CATCH-LIFE-MELD score, has been developed to predict short-term survival outcomes in patients with acute-on-chronic liver failure. The model's enhanced accuracy allows clinicians to identify high-risk patients who may benefit from urgent interventions, such as liver transplantation.
The updated ASTRO guideline recommends personalized treatment approaches for patients with locally advanced rectal cancer, including non-surgical alternatives and intensified treatment regimens. The guideline aims to improve outcomes while preserving quality of life.
Researchers are developing a novel vaccine and exploring the use of bile acids to fight necrotic enteritis, a preventable intestinal disease in poultry that costs the industry up to $6 billion annually. The vaccine, known as MEFA, targets multiple virulence points of the disease-causing pathogen, providing better protection against inf...
A comprehensive map of gene expression in the mouse intestine reveals unique regions tightly regulated by the immune system, including a region controlled by immune signals. The findings suggest resilience and adaptability of the intestine to perturbations.
Researchers at Karolinska Institutet have identified a molecule that can promote mucosal healing through tissue regeneration, potentially treating inflammatory bowel disease and colorectal cancer. The study found that activation of the Liver X receptor suppresses tumor growth in colorectal cancer, offering new therapeutic strategies.
Researchers have created the world's largest freely-available resource of human gut cells, mapping 1.6 million cells to identify new ways to treat disease. The study highlights a specific gut cell type involved in inflammation, potentially leading to new targets for IBD treatment and bowel cancer prevention.
Researchers have reviewed the therapeutic potential of extracellular vesicles derived from mesenchymal stem cells in treating inflammatory bowel disease. The study highlights the immunomodulatory, pro-regenerative, and anti-apoptotic properties of these vesicles, which may offer a safer alternative to conventional therapies.
Researchers have developed a new class of oral painkillers to suppress chronic abdominal pain. The painkillers are based on the peptide hormone oxytocin, which drives childbirth contractions, and work in the colon without crossing into the bloodstream.
Research highlights edoxaban's effectiveness in reducing stroke and blood clots for patients after bioprosthetic heart valve replacement. Edoxaban was found to be equally or more effective than warfarin, with a predictable pharmacokinetic profile and reduced burden on patients.
A new UC Davis Health study has uncovered the mechanisms by which Salmonella bacteria evade the body's natural defenses in the gut. The research found that Salmonella alters the gut's nutrient environment to fuel its replication in the large intestine, creating an imbalance that helps the pathogen survive. This new understanding could ...
Scientists at UMC Utrecht developed a new technology to isolate and study gut bacteria recognized by IgA antibodies, which are associated with various diseases. The next-generation IgA-SEQ method allows for high-throughput identification and analysis of these immunostimulatory bacteria, shedding light on their role in health and disease.
A new scientific statement highlights improvements in diagnosis, initial treatment, and long-term management of patients with Kawasaki Disease, emphasizing the need for tailored management strategies. Advances in cardiac imaging techniques and risk categorization have led to better patient outcomes.
The winners of the Applied Microbiology International Horizon Awards 2024 have been named, including the One Health Microbiome Center at Penn State and researchers Dr. François Thomas and Dr. Helen Onyeaka.
Gastroschisis has transformed from a uniformly fatal condition to one with a high survival rate through surgical advancements. The review highlights innovations in neonatal surgery that improve quality of life and long-term health outcomes, focusing on preventative and corrective aspects of gastroschisis management.
A new study from the University of Copenhagen aims to replace fecal capsules with a standardized treatment using fermented feces. The method employs fermentation to cultivate beneficial microorganisms, producing a complex mixture of bacteria and bacteriophages that can fight gastrointestinal disorders.
Researchers developed an AI model that uses imaging data to detect less frequent gastrointestinal tract diseases. The model's anomaly detection approach allows it to reliably identify rare diseases without extensive training data.